Concerto Biosciences Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 21-50 Employees

Concerto Biosciences revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$31,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,200,000
Total funding	$24,500,000

Key Contacts at Concerto Biosciences

Stewart Campbell

Independent Director

Jared Kehe

Cofounder And Chief Scientific Officer

Keaton Armentrout

Director Of Engineering

Dylan West

Director Of Strategy & Business Development

Company overview

Headquarters	Cambridge, Massachusetts, United States
Phone number	+16175447044
Website	concertobio.com
NAICS	541714
Founded	2020
Employees	21-50
Socials

Concerto Biosciences Email Formats

Concerto Biosciences uses 2 email formats. The most common is {first name} (e.g., john@concertobio.com), used 75% of the time.

Format	Example	Percentage
{first name}	john@concertobio.com	75%
{first initial}	j@concertobio.com	25%

About Concerto Biosciences

Concerto Biosciences measures, maps, and harnesses the microbial world to create best-in-class therapies and products. These assets achieve real-world efficacy and durability through naturally occurring symbioses among microbes. Powering asset discovery is our intelligence platform: Our microbial community screening apparatus (kChip) generates the right data at the right scale (40M+ combinations constructed and measured so far) needed to train a generalized AI model (kAI) of microbial ecology. Our first market is skin health, where we’ve brought a live biotherapeutic candidate for eczema to the clinic (ENS-002, or “Ensemble No.2”, a trio of bacteria that counteracts S. aureus virulence) and formulated a postbiotic ferment for consumer use (CB-002). In our mission to solve diverse market pain points with microbial solutions, we are building a pipeline across dermatology, women’s health, and food science. Concerto partners with global organizations to bring our solutions to market, tapping into microbial ecology to meet 21st-century needs of people and planet.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

Director

Employees by Department

Concerto Biosciences has 10 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Concerto Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-04-22	4	$24,500,000
2024-10-27	13	N/A

Funding Insights

$24,500,000

Total funding amount

Number of funding rounds

Concerto Biosciences Tech Stack

Discover the technologies and tools that power Concerto Biosciences's digital infrastructure, from frameworks to analytics platforms.

Node.js

Programming languages

Tailwind CSS

UI frameworks

PWA

Miscellaneous

Apple iCloud Mail

Webmail

HSTS

Security

MailChimp

Google Analytics

Analytics

Three.js

JavaScript graphics

Emotion

Development

Headless UI

UI frameworks

Next.js

JavaScript frameworks

Google Tag Manager

Tag managers

Frequently asked questions

Concerto Biosciences is located in Cambridge, Massachusetts, US.

You can reach Concerto Biosciences at +16175447044.

Concerto Biosciences generates an estimated annual revenue of $1,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Concerto Biosciences has an estimated valuation of $3,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Concerto Biosciences was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Concerto Biosciences has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Concerto Biosciences has raised a total of $24,500,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.